Why we acquired iPLATO (myGP)
Huma & iPLATO (myGP) join to create new possibilities in healthcare and research
Huma’s acquisition of iPLATO (myGP) opens up a world of new possibilities. Welcoming iPLATO to the Huma family will help us accelerate digital-first delivery of healthcare and research and bring ‘hospitals at home’ and decentralized clinical trials to even more customers. Together we will demonstrate how the combination of two technologies can be leveraged to enable the shift from reactive to truly personalised, proactive delivery of healthcare and research.
In 2021 we published research detailing the predictive models we created to assess an individual’s short- and long-term risk of being affected by cardiovascular disease, Alzheimer’s disease, and developing complications from COVID-19, or to understand general wellness with a risk model on all-cause mortality. The peer-reviewed papers demonstrated high accuracy levels but for us, this was just the beginning. Over the last year, we have been working on improving these models, applying cutting edge machine learning approaches with highly promising preliminary results and further publications in the pipeline. Our ultimate goal is to provide individuals with clinically-validated digital tools that can be used for initial screening at population level and increasing risk awareness to empower people to take control over their own health.
iPLATO reaches more than 26m people in its network and increases the use of healthcare services by up to 65%. The impact of this was seen when an extra 13,000 women in London undertook cervical screening after being contacted through myGP’s service. We understand that population screening programmes provide significant benefits but they are not perfect and come with challenges. The risks and benefits need to be evaluated and reviewed regularly by expert bodies. Using digital tools at scale can enable better identification of individuals at risk and therefore delivery of more targeted approaches, with the individual in the driving seat.
Leveraging the ever-maturing smartphone technologies sitting in our pockets, we can put personal, often actionable, information at people’s fingertips and all of this can be done in the comfort of their own home. Through quick and engaging assessments, individuals can better understand their risk trajectories for a variety of different conditions, receive recommendations on how to reduce and alter their risk trajectory by making better lifestyle choices or if needed, book an appointment using myGP to see their doctor (virtually or in-person) for further assessments.
Despite anyone’s best efforts, people will still fall ill. When they do, the primary care physician can prescribe Huma’s remote monitoring technology so that clinicians and patients can monitor the data that matters most to their health. With real-time data, conditions can be managed more proactively, deteriorations can be detected earlier, medication regimens can be optimised faster, all leading to improved outcomes and overall, a better prognosis and improved patient satisfaction. The combination of the two platforms truly puts the patient in the centre, connected with their care team, enabling them to order repeat prescriptions remotely, have medication delivered and access all their personal medical records. From the perspective of healthcare professionals, improved visibility on patients’ health status and trajectory means they can see the right patient at the right time, increase clinical capacity without overburdening the scarce resources, intervene early to reduce complications and be more preventative and impactful on the overall delivery of care. So everyone wins.
This is the future of healthcare. We want to tackle the biggest killers of our time - cancer, heart disease and Covid-19. We want to help people live longer, fuller lives. Our next chapter starts right now.
Sign up to our webinar on 23 February at 12.30pm GMT to hear more: https://info.huma.com/iplato-webinar
AI detects patients at highest risk of COVID-19 mortality
Peer-reviewed research published in Nature Scientific Reports
Atos and Huma support Symbiosis Hospital to expand care capacity
Huma’s ‘hospital at home’ technology will expand care capacity in Pune, India by up to 60%
Breaking the bias in cardiovascular disease
How digital-first care and research can address the gender bias in cardiovascular disease
Decentralized trial sees increased adherence to heart medication
A study testing if a cardiac trial could be run entirely remotely found rapid recruitment, high engagement and that patients with low baseline increased their medication adherence from 85% to 96%.
Digital support against Covid-19 in Germany
Press release: German states focus on patient care via app
Driving Patient Safety with Digital Technology
Patient safety may be paramount across healthcare, but we are a long way from ‘first, do no harm’. The World Health Organisation (WHO) reports that medication errors cause US$ 42 billion of global total health expenditure worldwide, 50% of the overall preventable harm in medical care.
FT 1000: Huma named Europe's fastest growing healthcare company
Press release: Huma listed in the Top 25 for all sectors
Fierce biotech webinar
Taking the "clinic" out of clinical trials and healthcare: Bridging research and care with digital tools
Fixing the foundations: building a solid evidence base for digital health
Our Global Clinical Directors Arrash Yassaee and Peter Kirpalani-Collins explain the importance of clinical rigour and evidence generation in digital health and how we’re doing things differently here at Huma.
HSJ Value Awards 2021
Huma has been shortlisted as a finalist for the HSJ Value Awards 2021.
How can digital solutions empower and support heart failure patients?
We launched a 12-week remote patient monitoring pilot with Cwm Taf and Betsi Cadwaladr University Health Boards
How decentralized and hybrid trials can drive efficiencies beyond the pandemic
Huma’s Nico O'Kuinghttons discusses how we can drive more efficient decentralized and hybrid clinical trials post-pandemic
How our digital CVD risk model can help reduce avoidable deaths
Our research was published in European Heart Journal Digital Health (EHJ-DH)
How to design virtual wards: 5 tips to set you up for success
Our clinical deployment lead, Dr Terry Deeny shares his top tips for designing successful virtual ward programmes based on Huma’s experience supporting the NHS.
How we help tackle cardiac surgical waiting lists
We worked with Royal Brompton and Harefield hospitals to remotely monitor and prioritise deteriorating patients.
Medopad rebrands as Huma as it expands offerings and acquires AI and wearable tech startups
Huma Appoints Kaushik Gune as Head of U.S. Healthcare Business to Promote Adoption of Digital Health Solutions
Huma has appointed Kaushik Gune as the company’s new U.S. Head of Healthcare
Huma Press Release
NHS using Huma’s remote monitoring to care for patients with COVID-19 symptoms.
Huma Talks: How Covid-19 is advancing digital health
Listen to and share our first webinar on-demand.
Huma acquires iPLATO Healthcare to advance digital-first delivery of care
The two companies will combine their expertise to provide remote patient monitoring for NHS patients
Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care
Huma acquires AstraZeneca’s digital health platform AMAZE™ and AstraZeneca becomes a shareholder of Huma
Huma and RARE-X partner to accelerate research
Press release: RARE-X’s federated data platform will pair with Huma’s DCT platform to accelerate research
Huma and Tamer bring digital ‘hospital at home’ platform to the Kingdom of Saudi Arabia
Tamer will bring Huma’s ‘hospitals at home’ technology to the Kingdom of Saudi Arabia to tackle diabetes and cardiovascular disease.
Huma announces US expansion
Press release: Experienced industry leaders create founding US Huma team
Huma appoints Shahram Sharif as Chief Business Officer - Medtech to accelerate digital-first use in the medtech industry
Sharif joins Huma to lead business development activities for digital companion app product
Huma calls for safeguarding of scientific collaboration
CEO & Founder Dan Vahdat speaks at World Economic Forum event in Davos.
Huma collaborates with Bayer to advance precision treatment for lung cancer
Medical technology powered using artificial intelligence
Huma finds way to measure breathing rate using entry-level smartphone gyroscopes
Huma researchers have verified a way to measure breathing rate using the gyroscopes in entry-level smartphones.
Huma joins forces with independent healthcare provider to launch virtual ward service for the NHS
Huma and Xyla Elective Care will work together to deliver tech-enabled virtual wards for the NHS
Huma raises $130 million financing to scale its digital health platform for better care and research
Leading names in health and technology fund expansion
Huma wins prestigious Prix Galien USA 2021 award
Huma’s remote patient monitoring technology is awarded ‘pharma’s Nobel Prize’
Huma wins ‘best of the best’ Prix Galien International 2022 award
Huma has won the Prix Galien International 2022 ‘best of the best digital health product’ award for the impact of its remote patient monitoring platform across healthcare and research.
Huma’s collaborative Covid-19 project wins HSJ Value Award
Our teams enabled better patient care and doubled clinical capacity with our hospital at home technology.
Huma’s peer-reviewed research links bedtime with heart health
Our peer-reviewed research explored the link between time of sleep and risk of cardiovascular disease in over 88,000 people
Mediclinic Middle East launches Mediclinic at Home
A new remote care monitoring system for patients suffering from chronic conditions
Meet our exceptional partners
Including Bayer, Hitachi, Samsung, Sony Innovation Fund by IGV, Unilever & the PE fund HAT.
NHS Long Term Plan Webinar Series
How digital technology is helping to battle the growing waiting list backlog
Pharma and digital health must join forces for patients
Dan Vahdat, CEO and Founder of Huma, discusses how we are working with pharma partners to improve clinical outcomes through digital health solutions.q
Powering COVID-19 virtual wards for better patient outcomes
Researchers have found that COVID-19 mortality rates were up to four times lower and hospital stays decreased by forty percent with Huma’s technology¹.
Remote patient monitoring pilot shortlisted for two prestigious HSJ Awards
The project has been nominated in the ‘Digitising Patient Care’ category at the HSJ Awards and ‘Virtual or Remote Care Initiative of the Year’ category at the HSJ Patient Safety Awards.
Smith+Nephew partner with Huma
Press release: Smith+Nephew and Huma develop RPM app to assist the restart of UK orthopaedic surgery
Taking the ‘clinic’ out of clinical trials
Bridging research and care with digital tools
Ten highlights from 2021, our 10th anniversary year
How we’re helping ~two million users across our platforms and people around the world live longer, fuller lives
Virtual Wards vital to help NHS tackle ‘substantial’ pressures
Huma welcome the Government’s announcement to accelerate the roll out of digital technology to provide an extra 2,500 virtual ward ‘beds’¹.
Webinar: Advancing digital-first delivery of care
Huma and iPLATO (myGP) hosted a joint webinar on how we can bring digital-first care to patients at scale
Webinar: Bridging the digital divide for improved patient diversity
Huma joined leading industry experts for a Reuters Events webinar on fostering diversity in decentralized and hybrid clinical trials
Webinar: Bringing the hospital home via digital virtual wards
Watch our webinar with leaders from the NHS and the AHSH Network.
Webinar: Empowering patients and relieving pressure on the NHS
Learn how Huma’s technology helps clinicians improve outcomes for heart failure patients and identify deteriorating cardiac surgery patients with almost 90% specificity
£150,000 awarded for digital solutions in response to COVID-19
What Huma has learned from COVID-19
Three important lessons on how COVID-19 is shaping modern medicine
Why Samsung Next invested into Huma
We were drawn to Huma’s mission to power individualised healthcare outside of a traditional hospital.
Why we acquired iPLATO (myGP)
Huma & iPLATO (myGP) join to create new possibilities in healthcare and research
World Patient Safety Day: supporting medicine safety with digital tools
For World Patient Safety Day in 2022, our Global Clinical Director Peter Kirpalani-Collins explains how digital healthcare tools can help keep patients safe by monitoring their symptoms and medication use.